These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9920814)

  • 21. Selective activation of PPARgamma inhibits pancreatic cancer invasion and decreases expression of tissue plasminogen activator.
    Farrow B; O'Connor KL; Hashimoto K; Iwamura T; Evers BM
    Surgery; 2003 Aug; 134(2):206-12. PubMed ID: 12947319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostaglandin-J(2) upregulates expression of matrix metalloproteinase-1 independently of activation of peroxisome proliferator-activated receptor-gamma.
    Józkowicz A; Huk I; Nigisch A; Cisowski J; Weigel G; Dulak J
    Acta Biochim Pol; 2003; 50(3):677-89. PubMed ID: 14515149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-Regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer.
    Hisatake JI; Ikezoe T; Carey M; Holden S; Tomoyasu S; Koeffler HP
    Cancer Res; 2000 Oct; 60(19):5494-8. PubMed ID: 11034093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Troglitazone inhibits mitogenic signaling by insulin in vascular smooth muscle cells.
    Goetze S; Kim S; Xi XP; Graf K; Yang DC; Fleck E; Meehan WP; Hsueh WA; Law RE
    J Cardiovasc Pharmacol; 2000 May; 35(5):749-57. PubMed ID: 10813377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells.
    Hamaguchi E; Takamura T; Shimizu A; Nagai Y
    J Pharmacol Exp Ther; 2003 Dec; 307(3):987-94. PubMed ID: 14534369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 15-Deoxy-delta 12,14-prostaglandin J2 and thiazolidinediones activate the MEK/ERK pathway through phosphatidylinositol 3-kinase in vascular smooth muscle cells.
    Takeda K; Ichiki T; Tokunou T; Iino N; Takeshita A
    J Biol Chem; 2001 Dec; 276(52):48950-5. PubMed ID: 11687581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thiazolidinediones inhibit apoptosis and heat shock protein 60 expression in human vascular endothelial cells.
    Artwohl M; Hölzenbein T; Fürnsinn C; Freudenthaler A; Huttary N; Waldhäusl WK; Baumgartner-Parzer SM
    Thromb Haemost; 2005 May; 93(5):810-5. PubMed ID: 15886792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-gamma.
    Park KS; Ciaraldi TP; Lindgren K; Abrams-Carter L; Mudaliar S; Nikoulina SE; Tufari SR; Veerkamp JH; Vidal-Puig A; Henry RR
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2830-5. PubMed ID: 9709955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Troglitazone, but not rosiglitazone, inhibits Na/H exchange activity and proliferation of macrovascular endothelial cells.
    de Dios ST; Hannan KM; Dilley RJ; Hill MA; Little PJ
    J Diabetes Complications; 2001; 15(3):120-7. PubMed ID: 11358680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fenofibrate, troglitazone, and 15-deoxy-Delta12,14-prostaglandin J2 close KATP channels and induce insulin secretion.
    Shimomura K; Shimizu H; Ikeda M; Okada S; Kakei M; Matsumoto S; Mori M
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1273-80. PubMed ID: 15201343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes.
    Yamamoto K; Ohki R; Lee RT; Ikeda U; Shimada K
    Circulation; 2001 Oct; 104(14):1670-5. PubMed ID: 11581147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro.
    Marx N; Sukhova G; Murphy C; Libby P; Plutzky J
    Am J Pathol; 1998 Jul; 153(1):17-23. PubMed ID: 9665460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory activity of clinical thiazolidinedione peroxisome proliferator activating receptor-gamma ligands toward internal mammary artery, radial artery, and saphenous vein smooth muscle cell proliferation.
    de Dios ST; Bruemmer D; Dilley RJ; Ivey ME; Jennings GL; Law RE; Little PJ
    Circulation; 2003 May; 107(20):2548-50. PubMed ID: 12742988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Troglitazone and related compounds: therapeutic potential beyond diabetes.
    Fujiwara T; Horikoshi H
    Life Sci; 2000 Oct; 67(20):2405-16. PubMed ID: 11065164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of activation of peroxisome proliferator-activated receptor gamma (PPARgamma) on human monocyte function: PPARgamma ligands do not inhibit tumor necrosis factor-alpha release in human monocytic cell line THP-1.
    Naitoh T; Kitahara M; Tsuruzoe N
    Cell Biol Toxicol; 2000; 16(2):131-5. PubMed ID: 10917568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peroxisome proliferator-activated receptor gamma activators downregulate angiotensin II type 1 receptor in vascular smooth muscle cells.
    Takeda K; Ichiki T; Tokunou T; Funakoshi Y; Iino N; Hirano K; Kanaide H; Takeshita A
    Circulation; 2000 Oct; 102(15):1834-9. PubMed ID: 11023940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen attenuates endothelin-1 production by bovine endothelial cells via estrogen receptor.
    Akishita M; Kozaki K; Eto M; Yoshizumi M; Ishikawa M; Toba K; Orimo H; Ouchi Y
    Biochem Biophys Res Commun; 1998 Oct; 251(1):17-21. PubMed ID: 9790900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of troglitazone and pioglitazone on cytokine-mediated endothelial cell proliferation in vitro.
    Gralinski MR; Rowse PE; Breider MA
    J Cardiovasc Pharmacol; 1998 Jun; 31(6):909-13. PubMed ID: 9641476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Troglitazone induces apoptosis via the p53 and Gadd45 pathway in vascular smooth muscle cells.
    Okura T; Nakamura M; Takata Y; Watanabe S; Kitami Y; Hiwada K
    Eur J Pharmacol; 2000 Nov; 407(3):227-35. PubMed ID: 11068018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic potential of thiazolidinediones in activation of peroxisome proliferator-activated receptor gamma for monocyte recruitment and endothelial regeneration.
    Tanaka T; Fukunaga Y; Itoh H; Doi K; Yamashita J; Chun TH; Inoue M; Masatsugu K; Saito T; Sawada N; Sakaguchi S; Arai H; Nakao K
    Eur J Pharmacol; 2005 Jan; 508(1-3):255-65. PubMed ID: 15680279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.